FINRA Considering Revised Rules For High Risk Brokers

Financial industry regulators are seeking to put tougher rules in place to oversee the outside business activities of brokers and dealers, which could pose a risk to investors. 

As part of an ongoing review of its practices, the Financial Industry Regulatory Authority (FINRA) issued a regulatory notice (PDF) this month, which seeks comments on existing and proposed regulations design to oversee activities by broker-dealers outside of their firms. Comments are being taken until June 29, 2017.

“These rules were designed to protect investors from potentially problematic or risky activities that are unknown to the firm but could be perceived by the investing public as either part of the firm’s business or having the firm’s imprimatur,” FINRA explained in a press release. “In addition, the rules protect firms from reputational or litigation risks when employees engage in business and securities activities outside of the firm.”

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

FINRA is a non-governmental agency that oversees the financial industry, which is designed to provide investor protection and market integrity by writing and enforcing rules that govern the activities of 3,800 broker-dealers and more than 633,000 brokers.

The group is seeking feedback on how the current rules have performed thus far, and proposes changes that could increase sanctions against broker-dealers who take high-risk actions outside of their firm that could threaten their investors, could restrict some activities by firms, and could allow FINRA to level more severe disciplinary actions against broker-dealers who have a history of misconduct.

The proposed rule changes would also let FINRA disclose when a firm has increased requirements, such as mandatory recording of customer telephone conversations, due to a high amount of employees who have faced disciplinary action from FINRA.

The review and potential changes are part of what is called the FINRA360 Initiative. The initiative seeks to review all of FINRA’s operations and programs.

“Regularly reviewing significant rules to ensure they remain effective at protecting investors in an efficient manner is a key priority that aligns with our FINRA360 Initiative,” FINRA President and CEO Robert W. Cook said in the press release. “Successful self-regulation requires continuous renewal

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges
Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges (Posted 2 days ago)

A Wegovy gastroparesis lawsuit filed by a Pennsylvania couple accuses the manufacturer, Novo Nordisk, of failing to provide adequate warnings about the true risks of the injectable weight loss drug.

Lawyers
Lawyers "Optimistic" Suboxone Tolling Agreement Will Be Reached For Tooth Decay Lawsuits (Posted 2 days ago)

Plaintiffs and defendants involved in Suboxone tooth decay lawsuits say they are close to a deal that would allow the filing of federal complaints after some state statue of limitation laws would have disqualified plaintiffs from filing.

Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users
Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users (Posted 3 days ago)

New Jersey man indicates he has been left with permanent hearing impairment from Tepezza, alleging that Horizon Therapeutics failed to instruct doctors about the importance of conducting hearing tests on patients using the thyroid eye disease drug.